# Allogenic Mesenchymal Stem Cell Derived Exosome in Patients With Acute Ischemic Stroke

> **NCT03384433** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Isfahan University of Medical Sciences** · enrollment: 5 (estimated)

## Conditions studied

- Cerebrovascular Disorders

## Interventions

- **BIOLOGICAL:** exosome

## Key facts

- **NCT ID:** NCT03384433
- **Lead sponsor:** Isfahan University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-04-17
- **Primary completion:** 2021-06-17
- **Final completion:** 2021-12-17
- **Target enrollment:** 5 (ESTIMATED)
- **Last updated:** 2021-01-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03384433

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03384433, "Allogenic Mesenchymal Stem Cell Derived Exosome in Patients With Acute Ischemic Stroke". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03384433. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*